About
Theragen Bio

Global genome service provider and
AI-based biopharmaceutical company

Learn more
SCROLL

Newsroom

Find out the latest news about Theargen Bio

PR
[Press Release]Theragen Bio registers a patent for the AI platform DEEPOMICS® NEO for neoantigen vaccine design.

2023-12-06

[Press Release]Theragen Bio registers a patent for the AI platform DEEPOMICS® NEO for neoantigen vaccine design.
PR
[Press Release]Theragen Bio has obtained a patent for an NGS-based COVID-19 diagnostic and variant determination system for the advancement of infectious disease diagnosis.

2023-05-23

[Press Release]Theragen Bio has obtained a patent for an NGS-based COVID-19 diagnostic and variant determination system for the advancement of infectious disease diagnosis.
PR
[Press Release]Theragen Bio and Agilent Partner to Advance Bioinformatic Solutions for Cancer Genomic Profiling in South Korea

2023-04-26

[Press Release]Theragen Bio and Agilent Partner to Advance Bioinformatic Solutions for Cancer Genomic Profiling in South Korea

PR
[Press Release]Theragen Bio and KAD sign MOU for building a domestic sewer-based monitoring System

2023-04-25

[Press Release]Theragen Bio and KAD sign MOU for building a domestic sewer-based monitoring System
PR
[Press Release]Theragen Bio acquires patent for predicting primary sites of cancer of unknown primary using genomic data.

2023-03-21

[Press Release]Theragen Bio acquires patent for predicting primary sites of cancer of unknown primary using genomic data.
PR
[Press Release]Theragen Bio, registered 8 patents related to genomics analysis and published 21 papers.

2022-12-22

[Press Release]Theragen Bio, registered 8 patents related to genomics analysis and published 21 papers.
PR
[Press Release]Theragen Bio donates cosmetics worth KRW 125 million to underprivileged groups for year-end charity

2022-12-08

[Press Release]Theragen Bio donates cosmetics worth KRW 125 million to underprivileged groups for year-end charity
PR
[Press Release]Theragen Bio and Herbalife Korea launch jointly developed genetic analysis service Gene Start+

2022-08-08

[Press Release]Theragen Bio and Herbalife Korea launch jointly developed genetic analysis service Gene Start+
PR
[Press Release]Theragen Bio renews international standard information security certification ISO 27001 and ISO 27701 for 3 consecutive years ... Demonstrates excellence in personal information protection

2022-07-27

[Press Release]Theragen Bio renews international standard information security certification ISO 27001 and ISO 27701 for 3 consecutive years ... Demonstrates excellence in personal information protection
PR
[Press Release]Theragen Bio selected as the developer of AI software solutions for pediatric rare diseases by the Ministry of Science and ICT's evaluation agency.

2022-07-22

[Press Release]Theragen Bio selected as the developer of AI software solutions for pediatric rare diseases by the Ministry of Science and ICT's evaluation agency.
PR
[Press Release]Theragen Bio Releases The Results of Discovery of The MAST4 Protein, Controlling Bone Cartilage Differentiation Process in Nature Communications, Sister Journal of Nature

2022-07-19

[Press Release]Theragen Bio Releases The Results of Discovery of The MAST4 Protein, Controlling Bone Cartilage Differentiation Process in Nature Communications, Sister Journal of Nature
PR
[Press Release]Theragen Bio and Lotte HealthCare sign investment and strategic partnership agreement for joint healthcare research and new business development.

2022-07-13

[Press Release]Theragen Bio and Lotte HealthCare sign investment and strategic partnership agreement for joint healthcare research and new business development.
PR
[Press Release]Theragen Bio to participate in the 'Korean Chip Genome Information Production Project' led by the Korea Centers for Disease Control and Prevention Agency.

2022-06-07

[Press Release]Theragen Bio to participate in the 'Korean Chip Genome Information Production Project' led by the Korea Centers for Disease Control and Prevention Agency.
PR
[Press Release]Theragen Bio, designated as a clinical trial specimen analysis institution by the Ministry of Food and Drug Safety

2022-04-21

[Press Release]Theragen Bio, designated as a clinical trial specimen analysis institution by the Ministry of Food and Drug Safety
News
[etnews] "Genetics is based on innovation in the bio industry..."No regulatory frames in DTC

2022-04-19

[etnews] "Genetics is based on innovation in the bio industry..."No regulatory frames in DTC
News
[Korea Biomedical Review] Theragen Bio starts upgraded disease-predicting personal genetic testing

2022-04-13

[Korea Biomedical Review] Theragen Bio starts upgraded disease-predicting personal genetic testing
PR
[Press Release]Theragen Bio to launch HelloGene 4.0, a disease prediction genetic test

2022-04-13

[Press Release]Theragen Bio to launch HelloGene 4.0, a disease prediction genetic test
PR
[Press Release]Theragen Bio to acquire a patent of AI-Based Patient Classification Molecular Subtype Calculation Device, DeepOmics Marker™

2022-04-07

[Press Release]Theragen Bio to acquire a patent of AI-Based Patient Classification Molecular Subtype Calculation Device, DeepOmics Marker™
Notice
Notice for convocation of 1st general meeting of shareholders

2021-03-16

Notice for convocation of 1st general meeting of shareholders

Notice
Theragen Bio to launch a new journey 'Pangyo Era'

2020-09-21

Theragen Bio to launch a new journey 'Pangyo Era'
Close